Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Die-Smulders, C. E.
Right arrow Articles by Geraedts, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Die-Smulders, C. E.
Right arrow Articles by Geraedts, J. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 121, No. 8, 1557-1563, August 1, 1998
© 1998 Oxford University Press


Age and causes of death in adult-onset myotonic dystrophy

Abstract

Myotonic dystrophy is a relatively common type of muscular dystrophy, associated with a variety of systemic complications. Long term follow- up is difficult because of the slow progression. The objective of this study was to determine survival, age at death and causes of death in patients with the adult-onset type of myotonic dystrophy. A register of myotonic dystrophy patients was set up in Southern Limburg (the Netherlands), using data longitudinally collected over a 47-year period (1950-97). Survival for 180 patients (from the register) with adult- onset type myotonic dystrophy was established by the Kaplan-Meier method. The median survival was 60 years for males and 59 years for females. Survival of the patients was also estimated from the age of 15 years to the ages of 25, 45 and 65 years and compared with the expected survival of age- and sex-matched birth cohorts from the normal Dutch population. The observed survival to the ages of 25, 45 and 65 years was 99%, 88% and 18% compared with an expected survival of 99%, 95% and 78%, respectively. Thus, survival to the age of 65 in patients with adult-onset myotonic dystrophy is markedly reduced. A weak positive correlation between the CTG repeat length and younger age at death was found in the 13 patients studied (r = 0.50, P = 0.08). The cause of death could be determined in 70 of the 83 deceased patients. Pneumonia and cardiac arrhythmias were the most frequent primary causes of death, each occurring in approximately 30%, which was far more than expected for the general Dutch population. In addition, we assessed mobility in the years before death in a subgroup of 18 patients, as a reflection of the long-term physical handicap in myotonic dystrophy patients. Half of the patients studied were either partially or totally wheelchair-bound shortly before their death.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
A. D. Russo, M. Pace, F. Bellocci, M. C.E. Hermans, C. G. Faber, Y. M. Pinto, B. Vrtovec, F. Haddad, A. A. Sovari, S. C. Dudley Jr., et al.
Sudden Death in Myotonic Dystrophy
N. Engl. J. Med., October 9, 2008; 359(15): 1626 - 1629.
[Full Text] [PDF]


Home page
NEJMHome page
W. J. Groh, M. R. Groh, C. Saha, J. C. Kincaid, Z. Simmons, E. Ciafaloni, R. Pourmand, R. F. Otten, D. Bhakta, G. V. Nair, et al.
Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
N. Engl. J. Med., June 19, 2008; 358(25): 2688 - 2697.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C. Gagnon, L. Noreau, R. T Moxley, L. Laberge, S. Jean, L. Richer, M. Perron, S. Veillette, and J. Mathieu
Towards an integrative approach to the management of myotonic dystrophy type 1
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 800 - 806.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Mankodi, X. Lin, B. C. Blaxall, M. S. Swanson, and C. A. Thornton
Nuclear RNA Foci in the Heart in Myotonic Dystrophy
Circ. Res., November 25, 2005; 97(11): 1152 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. E. Schulz, A. D. McIntosh, M. R. Kasten, B. Wieringa, and H. F. Epstein
A Role for Myotonic Dystrophy Protein Kinase in Synaptic Plasticity
J Neurophysiol, March 1, 2003; 89(3): 1177 - 1186.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste, and D. Duboc
Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study
J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1645 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
Acute respiratory failure in a middle aged woman
Postgrad. Med. J., October 1, 2001; 77(912): 669d - 669.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Ertekin, N Yuceyar, I Aydogdu, and H Karasoy
Electrophysiological evaluation of oropharyngeal swallowing in myotonic dystrophy
J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 363 - 371.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Antonini, F. Giubilei, A. Mammarella, P. Amicucci, M. Fiorelli, F. Gragnani, S. Morino, V. Ceschin, P. V. Fragola, and M. Gennarelli
Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats
Neurology, October 24, 2000; 55(8): 1207 - 1209.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.